Mumbai: Haffkine Bio-Pharmaceuticals procurement cell will be seeking explanations from two pharmaceutical firms after it came to light that medicines.

Vildagliptin was generally shown to have a beneficial or neutral effect on lipid parameters; however, one study reported a small decrease in HDL cholesterol levels, ...

If vildagliptin is approved for marketing, it will add to the available treatment options for diabetes and will provide patients and health care providers with another noninjectable therapy option.